Activity Details
| Credit Types: |
AMA PRA Category 1 (CME) ACPE (CPE) |
| Credit/Hours: |
1.50 (CME) 1.50 (CPE) |
| Cost: | Free |
| Released: | May 15, 2008 |
| Expires: | May 15, 2009 |
| System Requirements: |
 Adobe Flash Player |
| Activity Rating: | 0 / 5 Stars 0 Total Rating |
| Rate This Activity: |
Faculty
Jamshed F. Kanga, MDChief, Division of Pediatric Pulmonary Medicine
University of Kentucky Medical Center
Professor of Pediatrics
University of Kentucky College of Medicine
Robert J. Kuhn, PharmDClinical Pharmacy Specialist in Pediatrics
University of Kentucky Medical Center
Professor of Pharmacy
University of Kentucky College of Pharmacy
Needs Statement
Asthma is the leading serious chronic illness of children in the U.S. In 2005, an estimated 6.5 million children under age 18 (almost 1.4 million under age 5) currently had asthma, 3.8 million of which had an asthma attack, and many others have "hidden" or undiagnosed asthma.In 2005, the highest current prevalence rate was seen in those 5-17 years of age (97.2 per 1,000 population), with rates decreasing with age. Overall, the rate in those under 18 (89.0 per 1,000) was much greater than those over 18 (72.1 per 1,000).
Asthma is the third leading cause of hospitalization among children under the age of 15. Approximately 32.6 percent of hospitalizations due to asthma in 2005 were in those under age 15, however, only 27.8 percent of the U.S. population was younger than 15 years of age.
Asthma is the most common cause of school absenteeism due to chronic disease; in 2003, children reporting at least one asthma attack aged 5 to 17 years missed 12.8 million school days due to the disease.
Target Audience
This activity is intended for pediatric physicians and pharmacists who treat asthma.Objectives
2. Review the prevalence of asthma in the USA;
3. Review the drug therapy available for the treatment of asthma;
4. Review the recent GINA and NIH guidelines for the management of asthma;
5. Understand the day to day management of asthma to achieve asthma control;
6. Improve patient acceptance of diagnosis and adherence to therapy.
Accreditation
MedicineThe University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
Pharmacy
The University of Kentucky College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity has been assigned ACPE # 022-000-08-088-H01-P and will award 1.50 contact hours (0.15 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Statements of credit will indicate hours and CEUs based on successful completion of a posttest (score 70% or higher) and will be issued upon completion of the activity. The college complies with the Criteria for Quality for continuing education programming.
Faculty Disclosure
Dr. Kuhn receives consultation fees from Novartis.Dr. Kanga has no relevant relationships to disclose.
